Alpha 2.0
Login Register
» Authors » Maureen Smith

Maureen Smith

Explore the profile of Maureen Smith including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 141
Citations 2038
Followers 0
Related Specialties
General Medicine
Health Services
Public Health
Top 10 Co-Authors
Martin Offringa
Beth K Potter
Nancy J Butcher
Andrea C Tricco
Dawn Stacey
Pranesh Chakraborty
David Moher
Sylvia Stockler
Peter Tugwell
Stuart G Nicholls
Published In
Res Involv Engagem
Health Expect
J Clin Epidemiol
BMC Public Health
Genet Med
Affiliations
Soon will be listed here.
Recent Articles
1.
The Effect of Patient Decision Aid Attributes on Patient Outcomes: A Network Meta-Analysis of a Systematic Review
Stacey D, Carley M, Gunderson J, Hsieh S, Kelly S, Lewis K, et al.
Med Decis Making . 2025 Feb; :272989X251318640. PMID: 39968925
Background: Patient decision aids (PtDAs) are effective interventions to help people participate in health care decisions. Although there are quality standards, PtDAs are complex interventions with variability in their attributes....
2.
Strategies and resources used by public health units to encourage COVID-19 vaccination among priority groups: a behavioural science-informed review of three urban centres in Canada
Langmuir T, Wilson M, McCleary N, Patey A, Mekki K, Ghazal H, et al.
BMC Public Health . 2025 Jan; 25(1):403. PMID: 39891139
Background: Ensuring widespread COVID-19 vaccine uptake is a public health priority in Canada and globally, particularly within communities that exhibit lower uptake rates and are at a higher risk of...
3.
Update to the PRISMA guidelines for network meta-analyses and scoping reviews and development of guidelines for rapid reviews: a scoping review protocol
Veroniki A, Hutton B, Stevens A, McKenzie J, Page M, Moher D, et al.
JBI Evid Synth . 2025 Jan; 23(3):517-526. PMID: 39829235
Objective: The objective of this scoping review is to develop a list of items for potential inclusion in the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) reporting guidelines...
4.
Cobuilding patient and public capacity in knowledge synthesis: designed and delivered by patient and public partners for patient and public partners
Smith M, Gunderson J, Sreetharan S, Chaudhry S, Tam C, Al-Khateeb S, et al.
J Clin Epidemiol . 2024 Dec; 179():111635. PMID: 39653088
Objectives: To describe the Strategy for Patient-Oriented Research Evidence Alliance's cocreation and evaluation of two capacity building courses on knowledge synthesis for patient and public partners. Study Design And Setting:...
5.
Building Engagement-Capable Environments for Health System Transformation: Development and Early Implementation of a Capability Framework for Patient, Family and Caregiver Engagement in Ontario Health Teams
Abelson J, Tripp L, Abdelhalim R, Hives L, Kristy B, Smith M, et al.
Health Expect . 2024 Nov; 27(6):e70083. PMID: 39492464
Introduction: Despite widespread calls to involve patients, families and caregivers (PFCs) as partners at all levels of health system planning and design, there is unevenness in how engagement efforts are...
6.
Review of clinical trials and guidelines for children and youth with mucopolysaccharidosis: outcome selection and measurement
Howie A, Tingley K, Inbar-Feigenberg M, Mitchell J, Angel K, Gentle J, et al.
Orphanet J Rare Dis . 2024 Oct; 19(1):393. PMID: 39443985
Background: To inform the development of a core outcome set (COS) for children and youth with mucopolysaccharidoses (MPS), we aimed to identify all outcomes and associated outcome measurement instruments that...
7.
Barriers and facilitators to designing, maintaining, and utilizing rare disease patient registries: a scoping review protocol
Stratton C, Taylor A, Konstantinidis M, McNiven V, Kannu P, Gill P, et al.
JBI Evid Synth . 2024 Oct; 23(3):546-553. PMID: 39428992
Objective: The objectives of this review are to identify barriers and facilitators to designing, maintaining, and utilizing rare disease patient registries; determine whether and how these differ among patient partners,...
8.
Establishing a Core Outcome Set for Creatine Transporter Deficiency and Guanidinoacetate Methyltransferase Deficiency
Nasseri Moghaddam Z, Reinhardt E, Thurm A, Potter B, Smith M, Graham C, et al.
medRxiv . 2024 Oct; PMID: 39371127
Creatine transporter (CTD) and guanidinoacetate methyltransferase (GAMT) deficiencies are rare inborn errors of creatine metabolism, resulting in cerebral creatine deficiency. Patients commonly exhibit intellectual and developmental disabilities, often accompanied by...
9.
Genetics Navigator: protocol for a mixed methods randomized controlled trial evaluating a digital platform to deliver genomic services in Canadian pediatric and adult populations
DAmours G, Clausen M, Luca S, Reble E, Kodida R, Assamad D, et al.
BMJ Open . 2024 Sep; 14(9):e090084. PMID: 39231549
Introduction: Genetic testing is used across medical disciplines leading to unprecedented demand for genetic services. This has resulted in excessive waitlists and unsustainable pressure on the standard model of genetic...
10.
Family-centred care interventions for children with chronic conditions: A scoping review
Chow A, Saad A, Al-Baldawi Z, Iverson R, Skidmore B, Jordan I, et al.
Health Expect . 2024 Aug; 27(1):e13897. PMID: 39102737
Introduction: Children with chronic conditions have greater health care needs than the general paediatric population but may not receive care that centres their needs and preferences as identified by their...